Insider Trading & Ownership - Celano Michael

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Celano Michael
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2023-05-17
Purchase
2023-05-18
2:13 pm
Larimar Therapeutics Inc.LRMRCelano Michael
Chief Financial Officer
5,000$3.7263$18,632112,746
(Direct)
View
2022-09-16
Purchase
2022-09-19
07:00 am
Larimar Therapeutics Inc.LRMRCelano Michael
Chief Financial Officer
31,746$3.15$100,00031,746
(Direct)
View
2022-08-12
Purchase
2022-08-16
4:01 pm
ORASURE TECHNOLOGIES INCOSURCelano Michael
Director
12,000$4.493$53,916111,823
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-01-17
Option Award
2024-01-19
4:32 pm
N/A
2034-01-17
Larimar Therapeutics Inc.LRMRCelano Michael
Chief Financial Officer
218,750$0331,496
(Direct)
View
2023-01-31
Option Award
2023-02-02
8:16 pm
N/A
2033-01-31
Larimar Therapeutics Inc.LRMRCelano Michael
Chief Financial Officer
196,000$0227,746
(Direct)
View
2022-05-16
Option Award
2022-05-18
4:06 pm
N/A
N/A
ORASURE TECHNOLOGIES INCOSURCelano Michael
Director
24,762$5.2599,823
(Direct)
View
2022-05-16
Tax Withholding
2022-05-18
4:06 pm
N/A
N/A
ORASURE TECHNOLOGIES INCOSURCelano Michael
Director
3,399$5.2599,823
(Direct)
View
2022-05-10
Option Award
2022-05-12
8:28 pm
N/A
2032-05-10
Larimar Therapeutics Inc.LRMRCelano Michael
Chief Financial Officer
20,000$020,000
(Direct)
View
2022-01-18
Option Award
2022-01-20
7:19 pm
N/A
2032-01-18
Larimar Therapeutics Inc.LRMRCelano Michael
Chief Financial Officer
80,000$080,000
(Direct)
View
2021-05-18
Option Award
2021-05-19
4:05 pm
N/A
N/A
ORASURE TECHNOLOGIES INCOSURCelano Michael
Director
Director
13,559$9.587578,460
(Direct)
View
2021-05-17
Tax Withholding
2021-05-19
4:05 pm
N/A
N/A
ORASURE TECHNOLOGIES INCOSURCelano Michael
Director
Director
2,041$9.501278,460
(Direct)
View
2021-01-19
Option Award
2021-01-21
10:55 am
N/A
2031-01-19
Larimar Therapeutics Inc.LRMRCelano Michael
Chief Financial Officer
42,000$042,000
(Direct)
View
2020-09-29
Option Award
2020-09-30
2:05 pm
N/A
2030-07-16
Larimar Therapeutics Inc.LRMRCelano Michael
Chief Financial Officer
84,100$084,100
(Direct)
View
2020-05-28
Option Award
2020-06-05
8:04 pm
N/A
2030-05-28
Larimar Therapeutics Inc.LRMRCelano Michael
Chief Financial Officer
60,479$060,479
(Direct)
View
2020-05-18
Option Award
2020-05-19
4:37 pm
N/A
N/A
ORASURE TECHNOLOGIES INCOSURCelano Michael
Director
Director
8,143$15.9666,942
(Direct)
View
2020-05-15
Tax Withholding
2020-05-19
4:37 pm
N/A
N/A
ORASURE TECHNOLOGIES INCOSURCelano Michael
Director
Director
3,843$16.0466,942
(Direct)
View
2019-05-21
Option Award
2019-05-22
5:06 pm
N/A
N/A
ORASURE TECHNOLOGIES INCOSURCelano Michael
Director
Director
15,330$8.4862,642
(Direct)
View